Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

Lutz Eric R.; Hoyos Valentina; Rudraraju Lakshmi; DeOliveira Elizabeth; Jana Srikanta; Weiss Ido; Borrello Ivan M.; Noonan Kimberly

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

【24h】

Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

机译：骨髓浸润淋巴细胞（MILS）为Car-T细胞疗法提供了一种强大的平台

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共2页
作者
Lutz Eric R.; Hoyos Valentina; Rudraraju Lakshmi; DeOliveira Elizabeth; Jana Srikanta; Weiss Ido; Borrello Ivan M.; Noonan Kimberly;
展开▼
作者单位

WindMIL Therapeut Baltimore MD USA;

Johns Hopkins Univ Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;

WindMIL Therapeut Baltimore MD USA;

WindMIL Therapeut Baltimore MD USA;

WindMIL Therapeut Baltimore MD USA;

WindMIL Therapeut Baltimore MD USA;

Johns Hopkins Univ Sidney Kimmel Comprehens Canc Ctr Baltimore MD USA;

WindMIL Therapeut Baltimore MD USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy [J] . Lutz Eric R., Hoyos Valentina, Rudraraju Lakshmi, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：骨髓浸润淋巴细胞（MILS）为Car-T细胞疗法提供了一种强大的平台
2. Quantitative characterization of T-cell repertoire alteration in Chinese patients with B-cell acute lymphocyte leukemia after CAR-T therapy [J] . Wang Xiujian, Hu Yongxian, Liu Xiao, Bone marrow transplantation . 2019,第12期

机译：Car-T治疗后中国B细胞急性淋巴细胞白血病患者T细胞曲目改变的定量表征
3. Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor [J] . Hong Pan, Wenjun Li, Ze Chen, Bioactive Materials . 2021,第4期

机译：单击血液和皮下异种移植肿瘤的强大促进细胞免疫疗法的Cel-T细胞工程
4. LEVERAGING BIOPROCESS PLATFORM TECHNOLOGY FOR THE DEVELOPMENT OF A ROBUST, SCALABLE, AND ECONOMIC MANUFACTURING PROCESS OF ALLOGENEIC CAR-T CELL THERAPY PRODUCTS [C] . Bernadette Dahlin Conference on advancing manufacture of cell and gene therapies . 2019

机译：充分利用生物过程平台技术开发鲁棒，可缩放且经济的异源CAR T细胞治疗产品生产过程
5. A Heavy-Chain-Only CAR-T Cell Therapy Elicits Comparable Antitumor Response Compared with Canonical CAR-T Cells [D] . Wang, Guanmeng . 2019

机译：与规范汽车-T细胞相比，仅重链的Cel-T细胞疗法引发了可比的抗肿瘤反应
6. Click CAR-T cell engineering for robustly boosting cell immunotherapy in blood and subcutaneous xenograft tumor [O] . Hong Pan, Wenjun Li, Ze Chen, 2021

机译：单击血液和皮下异种移植肿瘤的强大促进细胞免疫疗法的CAR-T细胞工程
7. Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced-Intensity Conditioning Creates a Platform for Immunotherapy with Donor Lymphocyte Infusion and Recipient Dendritic Cell Vaccination in Multiple Myeloma [O] . Levenga Henriëtte, Schaap Nicolaas, Maas Frans, 2010

机译：强度降低后的部分T细胞贫乏同种异体干细胞移植为多发性骨髓瘤的供体淋巴细胞输注和接受树突状细胞疫苗接种创造了免疫治疗的平台。

Marrow-Infiltrating Lymphocytes (MILs) Provide a Robust Platform for CAR-T Cell Therapy

著录项

相似文献

相关主题

期刊订阅